Properties (115)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
company
|
| gptkbp:acquisition |
gptkb:Prothena_Corporation
gptkb:Elan_Drug_Technologies gptkb:Elan_Pharmaceuticals gptkb:Acorda_Therapeutics gptkb:Neurocrine_Biosciences Elan's conjugate vaccine portfolio Progenics_Pharmaceuticals AstraZeneca's_drug_delivery_business Bristol-Myers_Squibb's_drug_delivery_business Elan's_Alzheimer's_drug_portfolio Elan's_DNA_vaccine_portfolio Elan's_Parkinson's_drug_portfolio Elan's_RNA_vaccine_portfolio Elan's_acute_disease_drug_portfolio Elan's_adjuvanted_vaccine_portfolio Elan's_anti-infective_drug_portfolio Elan's_antibody-drug_conjugate_portfolio Elan's_biologic_drug_portfolio Elan's_biomarker_drug_portfolio Elan's_biopharmaceutical_drug_portfolio Elan's_biosimilar_drug_portfolio Elan's_biosimilar_monoclonal_antibody_portfolio Elan's_cardiovascular_drug_portfolio Elan's_cell_therapy_drug_portfolio Elan's_chronic_disease_drug_portfolio Elan's_dermatology_drug_portfolio Elan's_diagnostic_drug_portfolio Elan's_drug_delivery_technology Elan's_fusion_protein_drug_portfolio Elan's_gastrointestinal_drug_portfolio Elan's_gene_therapy_drug_portfolio Elan's_geriatric_drug_portfolio Elan's_imaging_drug_portfolio Elan's_immunotherapy_drug_portfolio Elan's_inactivated_vaccine_portfolio Elan's_live_attenuated_vaccine_portfolio Elan's_mRNA_vaccine_portfolio Elan's_men's_health_drug_portfolio Elan's_metabolic_drug_portfolio Elan's_monoclonal_antibody_drug_portfolio Elan's_multiple_sclerosis_drug_portfolio Elan's_nanomedicine_drug_portfolio Elan's_nanoparticle_vaccine_portfolio Elan's_neurology_drug_portfolio Elan's_oncology_drug_portfolio Elan's_ophthalmology_drug_portfolio Elan's_orphan_drug_portfolio Elan's_pain_management_drug_portfolio Elan's_pediatric_drug_portfolio Elan's_peptide_drug_portfolio Elan's_personalized_medicine_drug_portfolio Elan's_polyclonal_antibody_drug_portfolio Elan's_preventive_drug_portfolio Elan's_protein_drug_portfolio Elan's_protein_subunit_vaccine_portfolio Elan's_rare_disease_drug_portfolio Elan's_regenerative_medicine_drug_portfolio Elan's_respiratory_drug_portfolio Elan's_small_molecule_drug_portfolio Elan's_therapeutic_drug_portfolio Elan's_therapeutic_monoclonal_antibody_portfolio Elan's_therapeutic_vaccine_portfolio Elan's_tissue_engineering_drug_portfolio Elan's_toxoid_vaccine_portfolio Elan's_urology_drug_portfolio Elan's_vaccine_drug_portfolio Elan's_viral_vector_vaccine_portfolio Elan's_women's_health_drug_portfolio |
| gptkbp:CEO |
gptkb:Kelly_Martin
|
| gptkbp:clinicalTrials |
Phase III trials
Phase I trials Phase II trials |
| gptkbp:discontinued |
2014
|
| gptkbp:employees |
1,000 (2013)
|
| gptkbp:founded |
1969
|
| gptkbp:founder |
gptkb:K._J._McCarthy
gptkb:Robert_A._Ingram |
| gptkbp:headquarters |
gptkb:Dublin,_Ireland
|
| https://www.w3.org/2000/01/rdf-schema#label |
Elan Corporation
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:keyPeople |
gptkb:John_H._McCarthy
gptkb:K._J._McCarthy gptkb:Kelly_Martin gptkb:Robert_A._Ingram David_E._H._McCarthy |
| gptkbp:parentCompany |
gptkb:Perrigo_Company_plc
|
| gptkbp:partnerships |
gptkb:AstraZeneca
gptkb:Johnson_&_Johnson gptkb:Bristol-Myers_Squibb gptkb:Pfizer gptkb:Merck_&_Co. AbbVie |
| gptkbp:patentCitation |
therapeutic agents
drug formulations delivery technologies |
| gptkbp:products |
biopharmaceuticals
drug delivery systems |
| gptkbp:researchFocus |
Alzheimer's disease
Parkinson's disease cancer metabolic disorders neurology autoimmune diseases multiple sclerosis cardiovascular diseases infectious diseases pain management |
| gptkbp:revenue |
$1.2 billion (2013)
|
| gptkbp:sells |
ELN
|
| gptkbp:stockExchange |
gptkb:NYSE
|
| gptkbp:stockSymbol |
ELN
|
| gptkbp:subsidiary |
gptkb:Elan_Drug_Technologies
gptkb:Elan_Pharmaceuticals,_Inc. |
| gptkbp:website |
www.elan.com
|